Preclinical News and Research

RSS
ISP of Chile approves Trigemina's protocol for Phase 2 clinical study of TI-001

ISP of Chile approves Trigemina's protocol for Phase 2 clinical study of TI-001

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Study evaluates efficacy of drug combinations in treating colorectal cancer

Study evaluates efficacy of drug combinations in treating colorectal cancer

Spectrum Pharmaceuticals begins Phase 2 clinical program for SPI-2012

Spectrum Pharmaceuticals begins Phase 2 clinical program for SPI-2012

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Using MRI to measure blood flow over atherosclerotic plaques can help identify high-risk plaques

Using MRI to measure blood flow over atherosclerotic plaques can help identify high-risk plaques

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

CHOP, Pfizer join forces to expedite novel treatments for children

CHOP, Pfizer join forces to expedite novel treatments for children

Three institutions partner to create research breakthroughs in children's health

Three institutions partner to create research breakthroughs in children's health

Clinical trial signals new era in treatment of neurodegererative disorders

Clinical trial signals new era in treatment of neurodegererative disorders

Researchers discover injectable protein to reverse symptoms of dangerous conditions

Researchers discover injectable protein to reverse symptoms of dangerous conditions

Polymer scaffolds can advance the development of cancer therapeutics

Polymer scaffolds can advance the development of cancer therapeutics

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

PARP inhibitors can be novel treatment strategy for cisplatin-resistant cancer

PARP inhibitors can be novel treatment strategy for cisplatin-resistant cancer

V/Q imaging can detect early stages of COPD

V/Q imaging can detect early stages of COPD

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.